- This event has passed.
FASTER FORWARD- When Vaccine Development Goes Virtual
December 2, 2020 @ 10:00 am - 11:00 am
While scientists race to understand Covid-19, the research industry is in the midst of its own “Industrial Revolution”. Virtual trials are now a reality—and we must learn to adapt. Virtual trials are the aggregation of safety and efficacy data from participants. These cutting-edge trials take full advantage of technologies, apps, monitoring devices, and social platforms to conduct various aspects of the clinical trial. All from the comfort and safety of the patients’ home. This includes telemedicine utilization for recruitment, informed consent, patient counseling, remote contacts as well as measurements of clinical endpoints through deployment of wearables, ePRO and other tools/devices. In this session with experts from Celerion, you will learn:
- How to achieve faster proof of concept for vaccine development using a trusted early development partner to accelerate the process from healthy normal evaluation to patient efficacy
- How rapid, close scientific consultation drives appropriate study design, endpoints, and clinical operational expertise
- How dedicated bioanalytical and clinical pharmacology sites work in tandem to sharing results in real-time for adaptive data-driven results
Zori Cheshmedzhieva, MD, VP, Global Clinical Development, Celerion
Dr. Cheshmedzhieva has more than 18 years experience in multinational global trial conduct and is responsible for leading Celerion Global Clinical Development services across Europe and North America. Based in Vienna, Austria, Zori is a Medical Doctor (MD) and holds a MBA in Healthcare Management with leadership and management skills in Pharma and Life Sciences.